MARIETTA, Pa., March 18, 2016 -- Donegal Group Inc. (NASDAQ:DGICA) (NASDAQ:DGICB) today announced revisions to its previously reported financial results for the fourth quarter and year ended December 31, 2015.
The revisions relate to the Company’s accounting for its purchase of 2,000,000 shares of treasury stock in December 2015. After discussing with its independent registered public accounting firm the facts and circumstances the Company considered in making judgments based on applicable accounting guidance with respect to the Company’s accounting for the purchase, the Company determined that the premium it paid over the fair market value of the treasury stock should be charged to expense rather than included in the cost of the treasury stock the Company purchased.
The revisions result in an increase to the Company’s expenses and a reduction in the Company’s net income in the amount of $5.8 million for both the fourth quarter and full year of 2015. The revisions have no income tax effect. As a result of the revisions, the Company’s earnings per share of its Class A common stock on a diluted basis decreased by 21 cents for both the fourth quarter and full year of 2015. The Company’s revised earnings per share of its Class A common stock on a diluted basis was 77 cents for the full year of 2015, compared to 55 cents for the full year of 2014.
The revisions do not change the Company’s reported total assets, total liabilities, total stockholders’ equity or book value per share at December 31, 2015.
“The revisions to our reported financial results do not include any changes that impact our reported insurance underwriting results for 2015, which reflected strong performance across nearly all lines of business and represented substantial improvement over the comparable underwriting results for 2014,” said Jeffrey D. Miller, Executive Vice President and Chief Financial Officer of Donegal Group Inc.
The Company will include financial statements that contain the revisions described above in its Form 10-K for the year ended December 31, 2015, which the Company expects to file with the Securities and Exchange Commission later today.
About the Company
Donegal Group Inc. is an insurance holding company whose insurance subsidiaries offer personal and commercial property and casualty lines of insurance in 21 Mid-Atlantic, Midwestern, New England and Southern states. The insurance subsidiaries of Donegal Group Inc. and Donegal Mutual Insurance Company conduct business together as the Donegal Insurance Group. The Donegal Insurance Group has an A.M. Best rating of A (Excellent).
The Company’s Class A common stock and Class B common stock trade on NASDAQ under the symbols DGICA and DGICB, respectively. As an effective acquirer of small to medium-sized “main street” property and casualty insurers, Donegal Group has grown profitably since its formation in 1986. The Company continues to seek opportunities for growth while striving to achieve its longstanding goal of outperforming the property and casualty insurance industry in terms of service, profitability and growth in book value.
For Further Information: Jeffrey D. Miller Executive Vice President & Chief Financial Officer Phone: (717) 426-1931 E-mail: [email protected]


JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group
Boeing Seeks FAA Emissions Waiver to Continue 777F Freighter Sales Amid Strong Cargo Demand
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement
Oracle Stock Surges After Hours on TikTok Deal Optimism and OpenAI Fundraising Buzz
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm
Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling
Nike Shares Slide as Margins Fall Again Amid China Slump and Costly Turnaround
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
Citi Appoints Ryan Ellis as Head of Markets Sales for Australia and New Zealand
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery 



